Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2018 1
2019 1
2020 2
2021 10
2022 10
2023 13
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Previous immunity shapes immune responses to SARS-CoV-2 booster vaccination and Omicron breakthrough infection risk.
Pérez-Alós L, Hansen CB, Almagro Armenteros JJ, Madsen JR, Heftdal LD, Hasselbalch RB, Pries-Heje MM, Bayarri-Olmos R, Jarlhelt I, Hamm SR, Møller DL, Sørensen E, Ostrowski SR, Frikke-Schmidt R, Hilsted LM, Bundgaard H, Nielsen SD, Iversen KK, Garred P. Pérez-Alós L, et al. Among authors: hansen cb. Nat Commun. 2023 Sep 12;14(1):5624. doi: 10.1038/s41467-023-41342-2. Nat Commun. 2023. PMID: 37699890 Free PMC article.
Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors.
Pérez-Alós L, Armenteros JJA, Madsen JR, Hansen CB, Jarlhelt I, Hamm SR, Heftdal LD, Pries-Heje MM, Møller DL, Fogh K, Hasselbalch RB, Rosbjerg A, Brunak S, Sørensen E, Larsen MAH, Ostrowski SR, Frikke-Schmidt R, Bayarri-Olmos R, Hilsted LM, Iversen KK, Bundgaard H, Nielsen SD, Garred P. Pérez-Alós L, et al. Among authors: hansen cb. Nat Commun. 2022 Mar 28;13(1):1614. doi: 10.1038/s41467-022-29225-4. Nat Commun. 2022. PMID: 35347129 Free PMC article.
Humoral Immune Responses after an Omicron-Adapted Booster BNT162b2 Vaccination in Patients with Lymphoid Malignancies.
Heftdal LD, Hansen CB, Hamm SR, Pérez-Alós L, Fogh K, Pries-Heje M, Hasselbalch RB, Møller DL, Gang AO, Ostrowski SR, Frikke-Schmidt R, Sørensen E, Hilsted L, Bundgaard H, Garred P, Iversen K, Sabin C, Nielsen SD, Grønbæk K. Heftdal LD, et al. Among authors: hansen cb. Viruses. 2023 Dec 20;16(1):11. doi: 10.3390/v16010011. Viruses. 2023. PMID: 38275946 Free PMC article.
Prevalence and duration of anti-SARS-CoV-2 antibodies in healthcare workers.
Johannesen CK, St Martin G, Lendorf ME, Gerred P, Fyfe A, Paton RS, Thompson C, Molsted S, Kann CE, Jensen CA, Hansen CB, Løkkegaard E, Christensen TB, Simons P, Fischer TK. Johannesen CK, et al. Among authors: hansen cb. Dan Med J. 2022 Apr 7;69(5):A11210843. Dan Med J. 2022. PMID: 35485785 Free article.
SARS-CoV-2 antibody dynamics over time and risk factors associated with infection and long COVID-19 symptoms in large working environments.
Hansen CB, Dvoncova K, Pérez-Alós L, Fogh K, Madsen JR, Garred CH, Jarlhelt I, Nielsen PB, Petersen SS, Fjordager CG, Lauritsen KT, Hilsted L, Boding L, Iversen KK, Hyveled L, Garred P. Hansen CB, et al. J Intern Med. 2023 Jun;293(6):763-781. doi: 10.1111/joim.13637. Epub 2023 Apr 17. J Intern Med. 2023. PMID: 37024264
Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection.
Rezahosseini O, Hamm SR, Heftdal LD, Pérez-Alós L, Møller DL, Perch M, Madsen JR, Hald A, Hansen CB, Armenteros JJA, Pries-Heje MM, Hasselbalch RB, Fogh K, Frikke-Schmidt R, Hilsted LM, Sørensen E, Ostrowski SR, Harboe ZB, Iversen K, Bundgaard H, Sørensen SS, Rasmussen A, Garred P, Nielsen SD. Rezahosseini O, et al. Among authors: hansen cb. Front Immunol. 2023 Jan 13;13:1075423. doi: 10.3389/fimmu.2022.1075423. eCollection 2022. Front Immunol. 2023. PMID: 36713395 Free PMC article.
SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation.
Jarlhelt I, Nielsen SK, Jahn CXH, Hansen CB, Pérez-Alós L, Rosbjerg A, Bayarri-Olmos R, Skjoedt MO, Garred P. Jarlhelt I, et al. Among authors: hansen cb. Front Immunol. 2021 Nov 2;12:767981. doi: 10.3389/fimmu.2021.767981. eCollection 2021. Front Immunol. 2021. PMID: 34804055 Free PMC article.
Humoral and cellular immune responses after three or four doses of BNT162b2 in patients with hematological malignancies.
Heftdal LD, Hamm SR, Pérez-Alós L, Madsen JR, Armenteros JJA, Fogh K, Kronborg CC, Vallentin AP, Hasselbalch RB, Møller DL, Hansen CB, Pries-Heje M, Gang AO, Ostrowski SR, Frikke-Schmidt R, Sørensen E, Hilsted L, Bundgaard H, Iversen K, Garred P, Nielsen SD, Grønbaek K. Heftdal LD, et al. Among authors: hansen cb. Eur J Haematol. 2023 Aug;111(2):229-239. doi: 10.1111/ejh.13986. Epub 2023 May 8. Eur J Haematol. 2023. PMID: 37151174
Humoral response to two doses of BNT162b2 vaccination in people with HIV.
Heftdal LD, Knudsen AD, Hamm SR, Hansen CB, Møller DL, Pries-Heje M, Fogh K, Hasselbalch RB, Jarlhelt I, Pérez-Alós L, Hilsted LM, Ostrowski SR, Gerstoft J, Grønbaek K, Bundgaard H, Iversen K, Garred P, Nielsen SD. Heftdal LD, et al. Among authors: hansen cb. J Intern Med. 2022 Apr;291(4):513-518. doi: 10.1111/joim.13419. Epub 2021 Dec 16. J Intern Med. 2022. PMID: 34841629 Free PMC article.
Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV - a prospective observational cohort study.
Heftdal LD, Pérez-Alós L, Hasselbalch RB, Hansen CB, Hamm SR, Møller DL, Pries-Heje M, Fogh K, Gerstoft J, Grønbæk K, Ostrowski SR, Frikke-Schmidt R, Sørensen E, Hilsted L, Bundgaard H, Garred P, Iversen K, Sabin C, Nielsen SD. Heftdal LD, et al. Among authors: hansen cb. EBioMedicine. 2023 Jul;93:104661. doi: 10.1016/j.ebiom.2023.104661. Epub 2023 Jun 16. EBioMedicine. 2023. PMID: 37331161 Free PMC article.
31 results